{
  "zip": "02464",
  "sector": "",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Bioxytran, Inc., an early stage pharmaceutical company, focuses on the development, manufacture, and commercialization of various therapeutic drugs to address hypoxia in humans. The company's lead pharmaceutical drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for the treatment of patients with ischemia of the brain resulting from a stroke or the blockage of the blood vessels to the brain. Its products also include BXT-252, an injectable anti-necrosis drug to treat a wound that does not heal because limited amount of oxygen reaching the wound. The company was founded in 2017 and is headquartered in Newton, Massachusetts.",
  "city": "Newton",
  "phone": "617 454 1199",
  "state": "MA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.bioxytraninc.com",
  "maxAge": 1,
  "address1": "233 Needham Street",
  "industry": "",
  "address2": "Suite 300",
  "previousClose": 0.24,
  "regularMarketOpen": 0.19,
  "twoHundredDayAverage": 0.16468044,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.24,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.24,
  "fiftyDayAverage": 0.24084546,
  "trailingAnnualDividendRate": null,
  "open": 0.19,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -4.79216,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.24,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1843,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 23287606,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3075,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.24,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1843,
  "fiftyTwoWeekHigh": 1.11,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0003,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.24,
  "exchange": "PNK",
  "shortName": "BIOXYTRAN INC",
  "longName": "Bioxytran, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BIXT",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_582854619",
  "uuid": "9566f817-e5bc-303c-95ad-b5b5d6ca795c",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 97031696,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.022,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -2333792,
  "trailingEps": -0.026,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.83179003,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 16158423,
  "enterpriseValue": 24937380,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1535328000,
  "lastSplitFactor": "1:30",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.19,
  "logo_url": "https://logo.clearbit.com/bioxytraninc.com"
}